Pharmacosurveillance – Pharmacovigilance (1)
mardi 15 juin 2021
Sessions parallèles de communications orales
Sessions parallèles de communications orales
•
S28
•
11h10
>
12h10
•
Pharmacosurveillance – Pharmacovigilance (1)
•
Grande salle
Sessions parallèles de communications orales
Modérateurs : Bénédicte Lebrun-Vignes, Marine Auffret
•
CO-044
•
CO-044 - Cardiovascular adverse events in adults treated with intravitreal anti-vascular endothelial growth factor (anti-VEGF): systematic review and meta-analysis of randomized controlled trials
>
N.
Nadège
Ngo-Ntjam
•
CO-045
•
CO-045 - Cardiovascular adverse drug reactions of Ibrutinib, Idelalisib, Acalabrutinib and Venetoclax used in chronic lymphocytic leukemia: Systematic review - meta-analysis and Signal detection by disproportionality analysis from VigiBase®
>
F.
Fabien
DESPAS
•
CO-046
•
CO-046 - Medication errors in community and hospital geriatric populations: a 5-year retrospective analysis on the French national medication error reporting system
>
C.
Christine
AZAR
•
CO-047
•
CO-047 - Immune checkpoint inhibitors and serious infections: a case/non-case study in FAERS database
>
F.
Francesco
Salvo
•
CO-048
•
CO-048 - Serious atrial fibrillation associated with immune checkpoint inhibitor in cancer patients: a systematic review and meta-analysis of RCT.
>
C.
Charles
Dolladille
|